{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:28:49Z","timestamp":1785259729272,"version":"3.55.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,6]]},"abstract":"<jats:p>Hyperparathyroidism, an endocrine disorder linked to hypercalcemia, increases with age, particularly in those over 60. Abnormal lipid metabolism may be closely related to its occurrence and progression. The study used Mendelian randomization (MR) analysis on 179 lipid traits against hyperparathyroidism in the Finngen and UK Biobank (UKB) databases. Meta-analysis of inverse variance weighted results followed, with significance <jats:italic toggle=\"yes\">P<\/jats:italic>-values corrected for multiple comparisons. Causal validation was performed between positive lipids and renal failure, and MR analysis examined the link between renal failure and hyperparathyroidism. Reverse causal validation was also conducted between lipids and hyperparathyroidism, positive lipids and renal failure, and renal failure and hyperparathyroidism. The study conducted causal validation between 179 lipid traits and hyperparathyroidism, also exploring intermediary factors. Ultimately, MR analysis was performed on triacylglycerol (52:3) levels with hyperparathyroidism in both Finngen and UKB databases, followed by meta-analysis and multiple corrections. The results showed an odds ratio (OR) of 1.147 (95% confidence interval [CI]: 1.065\u20131.235, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.040). The MR results for triacylglycerol (52:3) levels and renal failure indicated an OR of 1.054 (95% CI: 1.004\u20131.106, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.032). For the intermediary factor renal failure, MR analysis with hyperparathyroidism in both Finngen and UKB databases followed by meta-analysis showed an OR of 1.336 (95% CI: 1.193\u20131.495, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20054.78\u2005\u00d7\u200510<jats:sup>\u22127<\/jats:sup>). Notably, no significant associations were found in the reverse validation of each analysis process. Furthermore, the mediation effect was \u03b2<jats:sub>12<\/jats:sub>\u2005=\u20050.0153, and the direct effect was \u03b2<jats:sub>3<\/jats:sub>\u2005=\u20050.1207 (0.1183, 0.1230). The mediation effect accounted for 11.25%, while the direct effect accounted for 88.75% of the total effect, <jats:italic toggle=\"yes\">Z<\/jats:italic>\u2005=\u200512.5, indicating that the direct effect predominantly influences the overall impact. The research shows that triacylglycerol (52:3) levels can directly increase the risk of hyperparathyroidism. It also raises the risk indirectly by increasing the likelihood of renal failure, an intermediary factor. About one-tenth of the lipid\u2019s effect on hyperparathyroidism is mediated through renal failure, while the direct effect constitutes roughly nine-tenths of the total effect.<\/jats:p>","DOI":"10.1097\/md.0000000000042580","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:01:49Z","timestamp":1749502909000},"page":"e42580","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Causal validation between 179 lipids and hyperparathyroidism: A bidirectional Mendelian randomization combined meta-analysis with mediation factors"],"prefix":"10.1097","volume":"104","author":[{"given":"Chongyang","family":"Zhu","sequence":"first","affiliation":[{"name":"Eastern Michigan Joint College of Engineering, Beibu Gulf University, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanxian","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, First People\u2019s Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4579-0236","authenticated-orcid":false,"given":"Jingze","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgery, First People\u2019s Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250609","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"R2-20250609","first-page":"e43","article-title":"Primary hyperparathyroidism.","volume":"379","author":"Choy","year":"2018","journal-title":"N Engl J Med"},{"key":"R3-20250609","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus.","volume":"28","author":"Khan","year":"2017","journal-title":"Osteop Int"},{"key":"R4-20250609","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20250609","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jc.2014-2000","article-title":"The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.","volume":"99","author":"Udelsman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250609","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2008.03520.x","article-title":"Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK.","volume":"71","author":"Yu","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R7-20250609","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20250609","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20250609","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/bmj.327.7414.530","article-title":"Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism.","volume":"327","author":"Vestergaard","year":"2003","journal-title":"BMJ"},{"key":"R10-20250609","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","article-title":"Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010).","volume":"73","author":"Griebeler","year":"2015","journal-title":"Bone"},{"key":"R11-20250609","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2005.11.046","article-title":"Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.","volume":"47","author":"Grundy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250609","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. the road ahead.","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"R13-20250609","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"R14-20250609","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3132\/dvdr.2008.046","article-title":"The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.","volume":"5","author":"Fruchart","year":"2008","journal-title":"Diabetes Vasc Dis Res"},{"key":"R15-20250609","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.2795","article-title":"Common variants associated with plasma triglycerides and risk for coronary artery disease.","volume":"45","author":"Do","year":"2013","journal-title":"Nat Genet"},{"key":"R16-20250609","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1210\/jc.2009-1086","article-title":"Carotid vascular abnormalities in primary hyperparathyroidism.","volume":"94","author":"Walker","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20250609","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults.","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"R18-20250609","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes.","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R19-20250609","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4239\/wjd.v1.i5.141","article-title":"Role of the renin angiotensin system in diabetic nephropathy.","volume":"1","author":"Chawla","year":"2010","journal-title":"World J Diabetes"},{"key":"R20-20250609","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nephro.2018.04.002","article-title":"Intracellular organelles in health and kidney disease.","volume":"15","author":"Shamekhi Amiri","year":"2019","journal-title":"Nephrol Ther"},{"key":"R21-20250609","doi-asserted-by":"crossref","first-page":"e30556","DOI":"10.1016\/j.heliyon.2024.e30556","article-title":"Biological changes in human B-cell line Ramos (RA.1) related to increasing doses of human parathyroid hormone.","volume":"10","author":"Rios-Serna","year":"2024","journal-title":"Heliyon"},{"key":"R22-20250609","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R23-20250609","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).","volume":"7","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"R24-20250609","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands.","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr Rev"},{"key":"R25-20250609","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s12877-024-05039-5","article-title":"Appendicular lean mass and the risk of stroke and Alzheimer\u2019s disease: a Mendelian randomization study.","volume":"24","author":"Zhu","year":"2024","journal-title":"BMC Geriatr"},{"key":"R26-20250609","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1210\/clinem\/dgae359","article-title":"All three in one: it\u2019s a cohort, proteomics, and Mendelian randomization biomarker study.","volume":"110","author":"Wada","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R27-20250609","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jacc.2020.10.048","article-title":"Diet-derived circulating antioxidants and risk of coronary heart disease: a Mendelian randomization study.","volume":"77","author":"Luo","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R28-20250609","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","article-title":"Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"R29-20250609","doi-asserted-by":"crossref","first-page":"1364841","DOI":"10.3389\/fnut.2024.1364841","article-title":"Causal association of plasma circulating metabolites with nephritis: a Mendelian randomization study.","volume":"11","author":"Shao","year":"2024","journal-title":"Front Nutr"},{"key":"R30-20250609","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R31-20250609","doi-asserted-by":"crossref","first-page":"449","DOI":"10.12688\/wellcomeopenres.19995.2","article-title":"MendelianRandomization v0.9.0: updates to an R package for performing Mendelian randomization analyses using summarized data.","volume":"8","author":"Patel","year":"2023","journal-title":"Wellcome Open Res"},{"key":"R32-20250609","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"R33-20250609","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R34-20250609","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R35-20250609","doi-asserted-by":"crossref","first-page":"R195","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies.","volume":"27","author":"Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"key":"R36-20250609","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R37-20250609","doi-asserted-by":"crossref","first-page":"1370831","DOI":"10.3389\/fimmu.2024.1370831","article-title":"Investigation of the causal association between Parkinson\u2019s disease and autoimmune disorders: a bidirectional Mendelian randomization study.","volume":"15","author":"Yang","year":"2024","journal-title":"Front Immunol"},{"key":"R38-20250609","doi-asserted-by":"crossref","first-page":"1332530","DOI":"10.3389\/fcvm.2024.1332530","article-title":"Assessment of causal associations between obesity and peripheral artery disease: a bidirectional Mendelian randomization study.","volume":"11","author":"Huang","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R39-20250609","doi-asserted-by":"crossref","first-page":"105695","DOI":"10.1016\/j.jsbmb.2020.105695","article-title":"Effect of vitamin D nutrition on disease indices in patients with primary hyperparathyroidism.","volume":"201","author":"Rao","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R40-20250609","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review.","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"R41-20250609","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.ihj.2023.11.002","article-title":"Dyslipidemia in diabetes.","volume":"76","author":"Kalra","year":"2024","journal-title":"Indian Heart J"},{"key":"R42-20250609","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"R43-20250609","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux.","volume":"126","author":"Samuel","year":"2016","journal-title":"J Clin Invest"},{"key":"R44-20250609","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.atherosclerosis.2014.12.027","article-title":"Parathyroid hormone and calcium are independently associated with subclinical vascular disease in a community-based cohort.","volume":"238","author":"Hagstr\u00f6m","year":"2015","journal-title":"Atherosclerosis"},{"key":"R45-20250609","doi-asserted-by":"crossref","first-page":"6045","DOI":"10.1007\/s13277-015-4452-5","article-title":"Wnt\/\u03b2-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol"},{"key":"R46-20250609","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrm2654","article-title":"Beta-catenin hits chromatin: regulation of Wnt target gene activation.","volume":"10","author":"Mosimann","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R47-20250609","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity.","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R48-20250609","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2009.11.005","article-title":"Lipid droplets finally get a little R-E-S-P-E-C-T.","volume":"139","author":"Farese","year":"2009","journal-title":"Cell"},{"key":"R49-20250609","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1194\/jlr.R800018-JLR200","article-title":"Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.","volume":"49","author":"Yen","year":"2008","journal-title":"J Lipid Res"},{"key":"R50-20250609","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1042\/bse0420089","article-title":"Fatty acid metabolism in adipose tissue, muscle and liver in health and disease.","volume":"42","author":"Frayn","year":"2006","journal-title":"Essays Biochem"},{"key":"R51-20250609","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.atherosclerosis.2013.01.041","article-title":"Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.","volume":"228","author":"Dekker","year":"2013","journal-title":"Atherosclerosis"},{"key":"R52-20250609","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.HYP.37.5.1242","article-title":"Alcohol consumption and the incidence of hypertension: the atherosclerosis risk in communities study.","volume":"37","author":"Fuchs","year":"2001","journal-title":"Hypertension"},{"key":"R53-20250609","doi-asserted-by":"crossref","first-page":"14821","DOI":"10.1038\/srep14821","article-title":"High-fat diet prevents adaptive peripartum-associated adrenal gland plasticity and anxiolysis.","volume":"5","author":"Perani","year":"2015","journal-title":"Sci Rep"},{"key":"R54-20250609","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.2337\/db08-0157","article-title":"Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.","volume":"57","author":"Sam","year":"2008","journal-title":"Diabetes"},{"key":"R55-20250609","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice.","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"key":"R56-20250609","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2015.11.015","article-title":"Saturated fatty acids trigger TLR4-mediated inflammatory response.","volume":"244","author":"Rocha","year":"2016","journal-title":"Atherosclerosis"},{"key":"R57-20250609","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000512218","article-title":"Epithelial-mesenchymal transition (EMT) as a therapeutic target.","volume":"211","author":"Jonckheere","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"R58-20250609","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157488408784293688","article-title":"Pioglitazone and rosiglitazone: effects of treatment with a thiazolidinedione on lipids and non conventional cardiovascular risk factors.","volume":"3","author":"Derosa","year":"2008","journal-title":"Curr Clin Pharmacol"},{"key":"R59-20250609","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.devcel.2023.05.009","article-title":"LC3B is lipidated to large lipid droplets during prolonged starvation for noncanonical autophagy.","volume":"58","author":"Omrane","year":"2023","journal-title":"Dev Cell"},{"key":"R60-20250609","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5650\/jos.ess16015","article-title":"Fatty acids and bioactive lipids of potato cultivars: an overview.","volume":"65","author":"Ramadan","year":"2016","journal-title":"J Oleo Sci"},{"key":"R61-20250609","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.3390\/nu15132998","article-title":"The mutual interplay between bone, glucose and lipid metabolism: the role of vitamin D and PTH.","volume":"15","author":"Danese","year":"2023","journal-title":"Nutrients"},{"key":"R62-20250609","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: a cross-sectional survey.","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"key":"R63-20250609","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3760\/cma.j.issn.0366-6999.20121642","article-title":"Association between dyslipidemia and chronic kidney disease: a cross-sectional study in the middle-aged and elderly Chinese population.","volume":"126","author":"Liu","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"R64-20250609","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1681\/ASN.2005121320","article-title":"Lipids and renal disease.","volume":"17","author":"Trevisan","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R65-20250609","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.trsl.2008.11.007","article-title":"Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.","volume":"153","author":"Moradi","year":"2009","journal-title":"Transl Res"},{"key":"R66-20250609","doi-asserted-by":"crossref","first-page":"e6075","DOI":"10.1590\/1414-431x20166075","article-title":"Obesity and kidney disease: hidden consequences of the epidemic.","volume":"50","author":"Kovesdy","year":"2017","journal-title":"Braz J Med Biol Res"},{"key":"R67-20250609","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"R68-20250609","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/jama.2010.39","article-title":"Relation between kidney function, proteinuria, and adverse outcomes.","volume":"303","author":"Hemmelgarn","year":"2010","journal-title":"JAMA"},{"key":"R69-20250609","doi-asserted-by":"crossref","first-page":"e197978","DOI":"10.1001\/jamanetworkopen.2019.7978","article-title":"Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers.","volume":"2","author":"Nho","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R70-20250609","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1320.001","article-title":"The role of the carnitine system in human metabolism.","volume":"1033","author":"Foster","year":"2004","journal-title":"Ann N Y Acad Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:02:00Z","timestamp":1749502920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":70,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042580","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}